CompletedNCT04037085
Ketamine After Cesarean Birth: Breastmilk Transfer and Effects
About this title
Read the official source — NCT04037085Medication studyAges 18–99United StatesDepression
Understand this study
Who was this study for?
Listed age limits: 18 years to 99 years.
What did participation involve?
The study group receives ketamine as a study medication.
- Listed locations
- Pittsburgh and 1 more locationSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateStarted: October 9, 2019
- Recruitment status
- Completed
- Enrollment listed in the registry
- 8
- Sponsor
- Grace Lim, MD, MS
- Sponsor type
- Individual investigator
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 99 Years
- Official registry ID
- NCT04037085
- Official title
Show the full official title
Evaluation of PK/PD, Breastmilk Transfer, and Effectiveness of Ketamine After Cesarean Delivery - Part 1
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Pittsburgh
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Grace Lim, MD, MS.
Did this study involve medication?
Yes. The study involved medication, including ketamine.
Who was this study for?
Listed age limits: 18 years to 99 years.
